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background: Transcatheter mitral valve repair with the MitraClip system for mitral regurgitation (MR) is a safe procedure. However its safety profile 
in patients with small body size is unclear.
Methods: In the present study, 157 consecutive patients who underwent the MitraClip procedure were divided into 2 groups based on body surface 
area (BSA): Small-BSA group (n=77) of BSA <1.84 m2, and Large-BSA group (n=80) of BSA ≥1.84 m2. BSA of 1.84 m2 was derived from the median 
value of the present cohort. The primary safety end point was freedom from a composite of major adverse events within 30 days.
results: Patients in the Small-BSA group, as compared with the Large-BSA group, were older (75.7 ± 13.8 years vs. 71.5 ± 11.4 years; p=0.04) and 
female predominant (59.7% vs. 23.8%; p<0.01), had a lower left ventricular ejection fraction (48.0 ± 20.2% vs. 55.3 ± 18.1%; p=0.02) and higher 
STS score (11.5 ± 9.2 vs. 7.0 ± 5.7; p<0.01). Procedural success (reduction of MR grade to ≤2+ at discharge) was similar in the Small- and Large-
BSA group (94.8% vs. 91.2%, respectively; p=0.38). Although there was no difference in the incidence of in-hospital adverse events between the 
Small- and Large-BSA group (1.3% vs. 1.2%; p=0.74), the length of hospital stay was longer in the Small-BSA group than the Large-BSA group (1.6 
± 1.4 days vs. 1.2 ± 0.8 days; p=0.04). The Small-BSA group, compared to the Large-BSA group had a lower primary safety end point (89% vs. 97%; 
p=0.04). Logistic regression analysis demonstrated small BSA (<1.84 m2) as an independent predictor of the primary safety end point (OR: 0.13, 
95% CI: 0.02 to 0.76, p = 0.02).
conclusions: A smaller body size was associated with a lower safety profile following the MitraClip procedure. This result suggests extra attention 
to peri-procedural care maybe warranted in these patients.
